Literature DB >> 31048794

Macrophage manipulation.

Anna Dart1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31048794     DOI: 10.1038/s41568-019-0148-2

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  3 in total

1.  Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression.

Authors:  Pieter Goossens; Juan Rodriguez-Vita; Anders Etzerodt; Marion Masse; Olivia Rastoin; Victoire Gouirand; Thomas Ulas; Olympia Papantonopoulou; Miranda Van Eck; Nathalie Auphan-Anezin; Magali Bebien; Christophe Verthuy; Thien Phong Vu Manh; Martin Turner; Marc Dalod; Joachim L Schultze; Toby Lawrence
Journal:  Cell Metab       Date:  2019-03-28       Impact factor: 27.287

2.  Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer.

Authors:  Christopher J Halbrook; Corbin Pontious; Ilya Kovalenko; Laura Lapienyte; Stephan Dreyer; Ho-Joon Lee; Galloway Thurston; Yaqing Zhang; Jenny Lazarus; Peter Sajjakulnukit; Hanna S Hong; Daniel M Kremer; Barbara S Nelson; Samantha Kemp; Li Zhang; David Chang; Andrew Biankin; Jiaqi Shi; Timothy L Frankel; Howard C Crawford; Jennifer P Morton; Marina Pasca di Magliano; Costas A Lyssiotis
Journal:  Cell Metab       Date:  2019-02-28       Impact factor: 27.287

3.  Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39.

Authors:  Maisa C Takenaka; Galina Gabriely; Veit Rothhammer; Ivan D Mascanfroni; Michael A Wheeler; Chun-Cheih Chao; Cristina Gutiérrez-Vázquez; Jessica Kenison; Emily C Tjon; Andreia Barroso; Tyler Vandeventer; Kalil Alves de Lima; Sonja Rothweiler; Lior Mayo; Soufiene Ghannam; Stephanie Zandee; Luke Healy; David Sherr; Mauricio F Farez; Alexandre Prat; Jack Antel; David A Reardon; Hailei Zhang; Simon C Robson; Gad Getz; Howard L Weiner; Francisco J Quintana
Journal:  Nat Neurosci       Date:  2019-04-08       Impact factor: 24.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.